Literature DB >> 25911754

CD8+ TCR Bias and Immunodominance in HIV-1 Infection.

Henrik N Kløverpris1, Reuben McGregor2, James E McLaren3, Kristin Ladell3, Mikkel Harndahl4, Anette Stryhn4, Jonathan M Carlson5, Catherine Koofhethile6, Bram Gerritsen7, Can Keşmir7, Fabian Chen8, Lynn Riddell9, Graz Luzzi10, Alasdair Leslie11, Bruce D Walker12, Thumbi Ndung'u13, Søren Buus4, David A Price3, Philip J Goulder2.   

Abstract

Immunodominance describes a phenomenon whereby the immune system consistently targets only a fraction of the available Ag pool derived from a given pathogen. In the case of CD8(+) T cells, these constrained epitope-targeting patterns are linked to HLA class I expression and determine disease progression. Despite the biological importance of these predetermined response hierarchies, little is known about the factors that control immunodominance in vivo. In this study, we conducted an extensive analysis of CD8(+) T cell responses restricted by a single HLA class I molecule to evaluate the mechanisms that contribute to epitope-targeting frequency and antiviral efficacy in HIV-1 infection. A clear immunodominance hierarchy was observed across 20 epitopes restricted by HLA-B*42:01, which is highly prevalent in populations of African origin. Moreover, in line with previous studies, Gag-specific responses and targeting breadth were associated with lower viral load set-points. However, peptide-HLA-B*42:01 binding affinity and stability were not significantly linked with targeting frequencies. Instead, immunodominance correlated with epitope-specific usage of public TCRs, defined as amino acid residue-identical TRB sequences that occur in multiple individuals. Collectively, these results provide important insights into a potential link between shared TCR recruitment, immunodominance, and antiviral efficacy in a major human infection.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25911754      PMCID: PMC4433859          DOI: 10.4049/jimmunol.1400854

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  85 in total

Review 1.  The molecular basis for public T-cell responses?

Authors:  Vanessa Venturi; David A Price; Daniel C Douek; Miles P Davenport
Journal:  Nat Rev Immunol       Date:  2008-03       Impact factor: 53.106

2.  Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection.

Authors:  Joshua J Obar; Kamal M Khanna; Leo Lefrançois
Journal:  Immunity       Date:  2008-05-22       Impact factor: 31.745

3.  Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid.

Authors:  Arne Schneidewind; Mark A Brockman; John Sidney; Yaoyu E Wang; Huabiao Chen; Todd J Suscovich; Bin Li; Rahma I Adam; Rachel L Allgaier; Bianca R Mothé; Thomas Kuntzen; Cesar Oniangue-Ndza; Alicja Trocha; Xu G Yu; Christian Brander; Alessandro Sette; Bruce D Walker; Todd M Allen
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

Review 4.  CD8+ T cell efficacy in vaccination and disease.

Authors:  Victor Appay; Daniel C Douek; David A Price
Journal:  Nat Med       Date:  2008-06       Impact factor: 53.440

5.  Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance.

Authors:  Maya F Kotturi; Iain Scott; Tom Wolfe; Bjoern Peters; John Sidney; Hilde Cheroutre; Matthias G von Herrath; Michael J Buchmeier; Howard Grey; Alessandro Sette
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

6.  Differential neutralization of human immunodeficiency virus (HIV) replication in autologous CD4 T cells by HIV-specific cytotoxic T lymphocytes.

Authors:  Huabiao Chen; Alicja Piechocka-Trocha; Toshiyuki Miura; Mark A Brockman; Boris D Julg; Brett M Baker; Alissa C Rothchild; Brian L Block; Arne Schneidewind; Tomohiko Koibuchi; Florencia Pereyra; Todd M Allen; Bruce D Walker
Journal:  J Virol       Date:  2009-01-21       Impact factor: 5.103

7.  Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection.

Authors:  Hayley Crawford; Julia G Prado; Alasdair Leslie; Stéphane Hué; Isobella Honeyborne; Sharon Reddy; Mary van der Stok; Zenele Mncube; Christian Brander; Christine Rousseau; James I Mullins; Richard Kaslow; Paul Goepfert; Susan Allen; Eric Hunter; Joseph Mulenga; Photini Kiepiela; Bruce D Walker; Philip J R Goulder
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

8.  The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain.

Authors:  Jeffrey Ishizuka; Guillaume B E Stewart-Jones; Anton van der Merwe; John I Bell; Andrew J McMichael; E Yvonne Jones
Journal:  Immunity       Date:  2008-02       Impact factor: 31.745

9.  Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication.

Authors:  Arne Schneidewind; Mark A Brockman; Ruifeng Yang; Rahma I Adam; Bin Li; Sylvie Le Gall; Charles R Rinaldo; Sharon L Craggs; Rachel L Allgaier; Karen A Power; Thomas Kuntzen; Chang-Shung Tung; Montiago X LaBute; Sandra M Mueller; Thomas Harrer; Andrew J McMichael; Philip J R Goulder; Christopher Aiken; Christian Brander; Anthony D Kelleher; Todd M Allen
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

10.  One-pot, mix-and-read peptide-MHC tetramers.

Authors:  Christian Leisner; Nina Loeth; Kasper Lamberth; Sune Justesen; Christina Sylvester-Hvid; Esben G Schmidt; Mogens Claesson; Soren Buus; Anette Stryhn
Journal:  PLoS One       Date:  2008-02-27       Impact factor: 3.240

View more
  17 in total

1.  Immune Control of HIV.

Authors:  Muthukumar Balasubramaniam; Jui Pandhare; Chandravanu Dash
Journal:  J Life Sci (Westlake Village)       Date:  2019-06

2.  Public T cell receptors confer high-avidity CD4 responses to HIV controllers.

Authors:  Daniela Benati; Moran Galperin; Olivier Lambotte; Stéphanie Gras; Annick Lim; Madhura Mukhopadhyay; Alexandre Nouël; Kristy-Anne Campbell; Brigitte Lemercier; Mathieu Claireaux; Samia Hendou; Pierre Lechat; Pierre de Truchis; Faroudy Boufassa; Jamie Rossjohn; Jean-François Delfraissy; Fernando Arenzana-Seisdedos; Lisa A Chakrabarti
Journal:  J Clin Invest       Date:  2016-04-25       Impact factor: 14.808

3.  The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity.

Authors:  Ludmila Danilova; Valsamo Anagnostou; Franck Housseau; Kellie N Smith; Justina X Caushi; John-William Sidhom; Haidan Guo; Hok Yee Chan; Prerna Suri; Ada Tam; Jiajia Zhang; Margueritta El Asmar; Kristen A Marrone; Jarushka Naidoo; Julie R Brahmer; Patrick M Forde; Alexander S Baras; Leslie Cope; Victor E Velculescu; Drew M Pardoll
Journal:  Cancer Immunol Res       Date:  2018-06-12       Impact factor: 11.151

4.  Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.

Authors:  Doty B A Ojwach; Daniel MacMillan; Tarylee Reddy; Vladimir Novitsky; Zabrina L Brumme; Mark A Brockman; Thumbi Ndung'u; Jaclyn K Mann
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

5.  Vulnerable targets in HIV-1 Pol for attenuation-based vaccine design.

Authors:  Doty B A Ojwach; Paradise Madlala; Michelle Gordon; Thumbi Ndung'u; Jaclyn K Mann
Journal:  Virology       Date:  2020-12-10       Impact factor: 3.616

6.  Dual HLA B*42 and B*81-reactive T cell receptors recognize more diverse HIV-1 Gag escape variants.

Authors:  Funsho Ogunshola; Gursev Anmole; Rachel L Miller; Emily Goering; Thandeka Nkosi; Daniel Muema; Jaclyn Mann; Nasreen Ismail; Denis Chopera; Thumbi Ndung'u; Mark A Brockman; Zaza M Ndhlovu
Journal:  Nat Commun       Date:  2018-11-27       Impact factor: 14.919

7.  HLA class-I-peptide stability mediates CD8+ T cell immunodominance hierarchies and facilitates HLA-associated immune control of HIV.

Authors:  Clarety Kaseke; Ryan J Park; Nishant K Singh; Dylan Koundakjian; Arman Bashirova; Wilfredo F Garcia Beltran; Overbeck C Takou Mbah; Jiaqi Ma; Fernando Senjobe; Jonathan M Urbach; Anusha Nathan; Elizabeth J Rossin; Rhoda Tano-Menka; Ashok Khatri; Alicja Piechocka-Trocha; Michael T Waring; Michael E Birnbaum; Brian M Baker; Mary Carrington; Bruce D Walker; Gaurav D Gaiha
Journal:  Cell Rep       Date:  2021-07-13       Impact factor: 9.423

8.  Impact of pre-adapted HIV transmission.

Authors:  Jonathan M Carlson; Victor Y Du; Nico Pfeifer; Anju Bansal; Vincent Y F Tan; Karen Power; Chanson J Brumme; Anat Kreimer; Charles E DeZiel; Nicolo Fusi; Malinda Schaefer; Mark A Brockman; Jill Gilmour; Matt A Price; William Kilembe; Richard Haubrich; Mina John; Simon Mallal; Roger Shapiro; John Frater; P Richard Harrigan; Thumbi Ndung'u; Susan Allen; David Heckerman; John Sidney; Todd M Allen; Philip J R Goulder; Zabrina L Brumme; Eric Hunter; Paul A Goepfert
Journal:  Nat Med       Date:  2016-05-16       Impact factor: 53.440

Review 9.  Role of HLA Adaptation in HIV Evolution.

Authors:  Henrik N Kløverpris; Alasdair Leslie; Philip Goulder
Journal:  Front Immunol       Date:  2016-01-18       Impact factor: 7.561

Review 10.  T Cell Receptor Profiling in Type 1 Diabetes.

Authors:  Laura M Jacobsen; Amanda Posgai; Howard R Seay; Michael J Haller; Todd M Brusko
Journal:  Curr Diab Rep       Date:  2017-10-11       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.